Third population-based immune surveillance study for the evaluation of the National Immunisation Programme in the Netherlands: the PIENTER3 study

Third population-based immune surveillance study for the evaluation of the National Immunisation Programme in the Netherlands: the PIENTER3 study - PIENTER3

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42468

Enrollment

8400

Registered

2015-10-07

Start date

2016-02-15

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immune system protection against infectious diseases

Interventions

None listed

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Subject is part of the study sample, aged 0 to 89 years old and has received a personal invitation for the PIENTER3 study. * Subject has given written Informed Consent (IC) before the start of the study visit.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The age-specific seroprevalence (immunity) for diseases included in the NIP of the Dutch general population.	—

Secondary

Measure	Time frame
The age-specific seroprevalence against other infectious diseases, in particular those that might be vaccine-preventable in the near future and against those diseases with a frequent subclinical course. By collecting additional samples, the relationship between immune status and carriage of potential pathogens, lifestyle factors and environmental factors can be studied.	—

Countries

Netherlands

Outcome results